Pierre Ruffiè
Eli Lilly (United States) · 134 works · 7,501 citations · h-index 30
Top works
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
- Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
- Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients
- Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma
- Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
- Pleural effusion: laboratory tests in 300 cases.
- Surgery for lung metastases from colorectal cancer: analysis of prognostic factors.
- Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer
- Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
- Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease
- The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma
- Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma
- Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
- Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancer
- Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.
- Combination of Raltitrexed and Oxaliplatin Is an Active Regimen in Malignant Mesothelioma: Results of a Phase II Study
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
- Pleural mesothelioma
- Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer
- Screening for Multiple Endocrine Neoplasia Type 1 and Hormonal Production in Apparently Sporadic Neuroendocrine Tumors1